Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Amgen
(NQ:
AMGN
)
325.39
+2.66 (+0.82%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Amgen
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
39
40
Next >
Income Investors: These 2 Stocks Have Quadrupled Their Dividend Payouts Over the Past 10 Years
April 06, 2023
These two stocks have generated massive dividend growth for shareholders in the last decade.
Via
The Motley Fool
3 Must-Buy Dow Stocks for Your April Buy List
April 05, 2023
The range of Dow stocks to choose from is small, but there are plenty of great opportunities for investors to choose from.
Via
InvestorPlace
3 Dow Stocks With Above-Average Dividends Yields to Buy in April
April 03, 2023
Income-seeking investors are going to love the annual payout raises and yields of 2.9% or better that these legendary dividend payers offer right now.
Via
The Motley Fool
1 Dividend Growth Stock to Buy Hand Over Fist
March 31, 2023
Investing in dividend stocks, particularly those that raise their payouts regularly, can pay off massively in time.
Via
The Motley Fool
Amgen's Debt Overview
March 31, 2023
Via
Benzinga
A Look Into Amgen Inc's Price Over Earnings
March 30, 2023
Via
Benzinga
Amgen Options Traders Betting On Stock Rising This Much By April Expiration
March 30, 2023
Within the next month, Amgen Inc. (NASDAQ: AMGN) is expected to report quarterly earnings at $4 per share on revenue of $6.26 billion, analysts say.
Via
Benzinga
Looking At Amgen's Recent Unusual Options Activity
March 20, 2023
Via
Benzinga
Amgen Unusual Options Activity For March 15
March 15, 2023
Via
Benzinga
Price Over Earnings Overview: Amgen
March 15, 2023
Via
Benzinga
This Blue Chip Dividend Stock Should Return to Form When the Risk Premium Flips
March 30, 2023
T-bills may be the flavor of the month, but history has shown this top biotech stock is a far better long-term investment.
Via
The Motley Fool
The Government Move That Could Drive Obesity Drugs — And Lilly, Novo Shares
March 29, 2023
The decision from the WHO could further bolster use of Novo's Saxenda and Wegovy.
Via
Investor's Business Daily
Up 463%, This Sizzling Growth Stock Could Have a Lot More Room to Run
March 29, 2023
Viking Therapeutics stock might in the midst of a historic run.
Via
The Motley Fool
Viking Therapeutics' Initial VK2735 'Data Resoundingly Beat Expectations,' Analyst Says
March 28, 2023
Earlier today, Viking Therapeutics Inc (NASDAQ: VKTX) announced the first-in-human single-ascending dose and multiple-ascending dose data of VK2735.
Via
Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend Yields
March 27, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
2 Top Biotech Stocks to Buy Right Now
March 15, 2023
These two companies are showering shareholders with market-topping payouts.
Via
The Motley Fool
Amgen Faces Lawsuit For Hiding Its Stupendous Tax Bill Of $10B
March 14, 2023
Via
Benzinga
Amgen's Debt Overview
March 14, 2023
Via
Benzinga
The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh Win
March 24, 2023
The company is working on an oral version of its cult-following injection, Ozempic.
Via
Investor's Business Daily
Nvidia's Artificial Intelligence Market Strategy Impresses Wall Street
March 22, 2023
Analysts on Wednesday praised Nvidia's approach to artificial intelligence as it moves deeper into software and services. NVDA stock rose.
Via
Investor's Business Daily
Nvidia Ramps Up Artificial Intelligence Offerings Amid AI's 'iPhone Moment'
March 21, 2023
Nvidia on Tuesday demonstrated how its technology is advancing artificial intelligence in myriad industries. Nvidia stock has soared in 2023.
Via
Investor's Business Daily
3 Dow Stocks Near 52-Week Lows That Look Like Bargains Now
March 20, 2023
These businesses are performing much better than their stock prices would suggest.
Via
The Motley Fool
Is It Time to Buy the Dow Jones' 3 Worst-Performing February (and Now March) Stocks?
March 16, 2023
Several blue chips have been routed lately, but most of their sell-offs were way overdone.
Via
The Motley Fool
What 14 Analyst Ratings Have To Say About Amgen
March 13, 2023
Via
Benzinga
2 Stocks to Buy Near Their 52-Week Lows That Could Help You Beat The Market
March 14, 2023
Let's follow one of the most basic investment tips: Buy low.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 13, 2023
March 13, 2023
Via
Benzinga
Nasdaq Futures Climb Solidly After Past Week's Rout: Analyst Flags Key S&P 500 Support To Stay Above October Lows
March 13, 2023
After the market mayhem seen last week, some semblance of normalcy could return to Wall Street, thanks to the government’s move to assuage concerns in response to the banking crisis.
Via
Benzinga
Hefty Listing Price Of New Drugs For Cancer, Rare Diseases Put Pressure On Annual Hike For Older Drugs
March 10, 2023
New branded medicines are coming to market with ever-higher price tags as soon as the first day. Amgen Inc's (NASDAQ: AMGN) lung cancer treatment, Lumakras, carried a hefty price tag of $17,900 per...
Via
Benzinga
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks Delivering High-Dividend Yields
March 10, 2023
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
A Bull Market Is Coming: 3 Stocks Near Their 52-Week Lows to Buy Now
March 08, 2023
It may only be a matter of time before these stocks start to rally.
Via
The Motley Fool
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
39
40
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.